2026.06.18 Grand Sonire Therapeutics Awarded $13 Million Through NEDO Deep-Tech Startups Support Program (DTSU) to Advance Global Commercialization of Pancreatic Cancer Treatment
2026.05.01 Press release Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
2026.04.16 Financing Sonire Therapeutics Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development
2026.01.05 Notice Clinical Research Results on Focused Ultrasound Therapy, the Technological Foundation of SONIRE Therapeutics, Published in “Ultrasound in Medicine & Biology”
2025.10.31 Notice SONIRE Therapeutics Announces Publication of Joint Research Results with Tokyo University of Pharmacy and Life Sciences
